Cyr61 inhibits NSCLC cell proliferation by upregulating p53, p21, and p130/Rb gene expression[15], suggesting that Cyr61 may induce senescence through a p53-/pRb-dependent pathway[36]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.